Wyeth v. Levine caused undeserved loss to Wyeth that will increase uncertainty in product labeling and hence increase litigation and losses for the entire industry, and will probably undermine future research too.
Early-stage renal masses should be treated with nephron-sparing approaches when possible.
Should Medicare pay for patient expenses the way automobile insurers pay for car-repair bills?
We lost my mom, Joni, a little over a year ago to kidney cancer and the Kidney Cancer Association is based in Chicago. I wanted to do something in honor of my mom and help them raise awareness.
KIDNEY cancer patients and leading specialists have slammed a proposal to stop providing three life-lengthening treatments on the NHS.
Richards was at the event supporting the Kidney Cancer Association, a cause close to her heart after she lost her mother to the disease a year ago.
Editorial: Should we let Washington bureaucrats decide when to pull the plug on us?
Lagging the USA by years, hundreds of Australian patients being treated for renal cell carcinoma - a major form of kidney cancer - will benefit from Government-subsidised access to sunitinib.
The National Institute for Health and Clinical Excellence has denied patients with kidney cancer access to Roches Avastin (bevacizumab), Bayers Nexavar (sorafenib) and Wyeths Torisel (temsirolimus) on the National Health Service.
The FDA granted orphan drug status to Oncophage as a brain cancer treatment, allowing up to 7 years of market exclusivity if approved for the indication.
|NeonCRM by Neon One|